Subscribe to Search results

In oral evidence Alice Mackie noted that the wife of a patient had recalled how her husband was always told there was nothing to worry about and that all blood donors had not had AIDS and that it had been safe

Published on:

In oral evidence Alice Mackie stated that the wife of a patient had recalled how they had believed that her husband had not been infected following a large group meeting as they had felt that had he been infected that they would have been told.

Published on:

There is evidence that blood was also taken from family members and used for research purposes, the nature of which remains unclear, with no explanation being given as to the purpose of the blood testing: see the evidence of Alice Mackie.

Published on:

Professor Christopher Ludlum explained that he had been unaware of the recommendations issued by the Council of Europe to avoid using coagulation factors

Published on:

Professor Christopher Ludlam confirmed that his handwriting had been on a first draft of the AIDS Advisory document written by Professor Bloom in which Bloom had asked for comments from Ludlam stating that recipients had not been informed of receiving an infected batch.

Published on:

It was not until 19 December 1984 (by which time Professor Ludlam had known the results for 16 patients, as well as a larger number of negative results, for nearly two months but had not told a single patient) that a group meeting took place to alert patients to what had happened. It was not until 1985 that the process of informing individual patients of their test results commenced

Published on:

Inquiry issues letter about compensation

Published on:

Inquiry round-up

Published on:

Inquiry receives letter from the Paymaster General

Published on:

In 1981 and 1982 Haemophilia A patients were primarily treated at the Royal Manchester Childrens' Hospital with commercial concentrate and no NHS concentrate was used at all.

Published on:

By September 1982, Cryoprecipitate tended to be used for hospital treatment and concentrates for home treatment at the Royal Manchester Childrens' Hospital .

Published on:

At the Royal Manchester Children's Hospital, parents were unaware that their children were being tested for HIV.

Published on:

Annual returns showed that there was no policy of restricting patients to single manufacturers or batches of commercial concentrate.

Published on:

Dr Evans said, treatment of cryoprecipitate was given to young patients with haemophilia rather than Factor VIII concentrates. The incidence of hepatitis was lower when using North Western Cryoprecipitate than imported concentrates. Concentrates were kept for home treatment versus cryoprecipitate for hospital treatment.

Published on:

Home treatment with an element of prophylaxis had been introduced in the early 1970s and families were advised some children may have an injection for a day, or for a period when bleeds are particularly troublesome.

Published on:

Dr Evans wrote to Dr Aronstam declaring he did not think it mattered which product was used so long as the concentrate is changed "from time to time".

Published on:

Dr Evans wrote to Dr Aronstam stating he though it sensible that patients don't become too dependent on one manufacturer's concentrates.

Published on:

There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at Royal Manchester Children's Hospital remained commercial concentrates, although NHS Factor 8 continued to be used as well.

Published on:

There was no discernible change of approach in 1983 and 1984, the predominant treatment for the children at RMCH remained commercial concentrates, although NHS Factor 8 continued to be used as well.

Published on:

In July 1983, Dr Aronstam wrote to Dr Evans which would have alerted him to the fact that Treloar's was undertaking AIDS related tests and looking for the stigmata of AIDS.

Published on: